NCT02472977View on ClinicalTrials.gov

Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 13, 2015

Primary Completion Date

January 27, 2017

Study Completion Date

January 27, 2017

Conditions
Solid Tumor
Interventions
DRUG

Ulocuplumab

DRUG

Nivolumab

Trial Locations (7)

10032

Columbia University Medical Center (Cumc), New York

10065

Memorial Sloan Kettering Cancer Center, New York

21287

Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore

46202

Indiana University Health, Indianapolis

80045

University Of Colorado Hosp, Aurora

84112

Huntsman Cancer Institute, Salt Lake City

00029

Local Institution, Helsinki

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY